Mood, anxiety, and physical illness: body and mind, or mind and body?
This research review examines the recent articles that have investigated the relationship between mood, anxiety, and physical illness (e.g., asthma, autoimmune disorders, cancer, cardiovascular disease, obesity, and sexual dysfunction). There is growing evidence of an overall negative impact of depression and other mood states, and anxiety on numerous physical illnesses and conditions, and their outcome.
Balon
Richard
R
Department of Psychiatry and Behavioral Neurosciences, Wayne State University School of Medicine, Detroit, Michigan 48207, USA. rbalon@wayne.edu
D001008:Anxiety Disorders / Q000188:drug therapy / Q000453:epidemiology* / Q000378:metabolism; D001327:Autoimmune Diseases / Q000453:epidemiology / Q000378:metabolism / Q000523:psychology; D015283:Citalopram / Q000627:therapeutic use; D015897:Comorbidity; D006304:Health Status; D006331:Heart Diseases / Q000453:epidemiology / Q000378:metabolism / Q000523:psychology; D006801:Humans; D006854:Hydrocortisone / Q000097:blood / Q000652:urine; D019964:Mood Disorders / Q000188:drug therapy / Q000453:epidemiology* / Q000378:metabolism; D009369:Neoplasms / Q000453:epidemiology / Q000378:metabolism / Q000523:psychology; D009765:Obesity / Q000453:epidemiology / Q000378:metabolism / Q000523:psychology; D011603:Psychophysiology; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D012735:Sexual Dysfunction, Physiological / Q000453:epidemiology / Q000378:metabolism / Q000523:psychology; D011795:Surveys and Questionnaires
D015283:Citalopram; D006854:Hydrocortisone; D017367:Selective Serotonin Reuptake Inhibitors